Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Chaplain care in pediatric oncology: Insight for interprofessional collaboration.

Lion AH, Skiles JL, Watson BN, Young JD, Torke AM.

Pediatr Blood Cancer. 2019 Dec;66(12):e27971. doi: 10.1002/pbc.27971. Epub 2019 Aug 20.

PMID:
31429523
2.

Influence of health insurance status on childhood cancer treatment outcomes in Kenya.

Olbara G, Martijn HA, Njuguna F, Langat S, Martin S, Skiles J, Vik T, Kaspers GJL, Mostert S.

Support Care Cancer. 2020 Feb;28(2):917-924. doi: 10.1007/s00520-019-04859-1. Epub 2019 Jun 7.

PMID:
31172285
3.

Transcatheter mitral repair: MitraClip technique.

Ramlawi B, Skiles J, Myers D, Ali O, Viens C.

Ann Cardiothorac Surg. 2018 Nov;7(6):824-826. doi: 10.21037/acs.2018.10.14. No abstract available.

4.

Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.

Li L, Sajdyk T, Smith EML, Chang CW, Li C, Ho RH, Hutchinson R, Wells E, Skiles JL, Winick N, Martin PL, Renbarger JL.

Clin Pharmacol Ther. 2019 Jun;105(6):1421-1428. doi: 10.1002/cpt.1324. Epub 2019 Jan 21.

PMID:
30506673
5.

The National Physicians Cooperative: transforming fertility management in the cancer setting and beyond.

Smith BM, Duncan FE, Ataman L, Smith K, Quinn GP, Chang RJ, Finlayson C, Orwig K, Valli-Pulaski H, Moravek MB, Zelinski MB, Irene Su H, Vitek W, Smith JF, Jeruss JS, Gracia C, Coutifaris C, Shah D, Nahata L, Gomez-Lobo V, Appiah LC, Brannigan RE, Gillis V, Gradishar W, Javed A, Rhoton-Vlasak AS, Kondapalli LA, Neuber E, Ginsberg JP, Muller CH, Hirshfeld-Cytron J, Kutteh WH, Lindheim SR, Cherven B, Meacham LR, Rao P, Torno L, Sender LS, Vadaparampil ST, Skiles JL, Schafer-Kalkhoff T, Frias OJ, Byrne J, Westphal LM, Schust DJ, Klosky JL, McCracken KA, Ting A, Khan Z, Granberg C, Lockart B, Scoccia B, Laronda MM, Mersereau JE, Marsh C, Pavone ME, Woodruff TK.

Future Oncol. 2018 Dec;14(29):3059-3072. doi: 10.2217/fon-2018-0278. Epub 2018 Nov 26.

6.

Continuous invasive hemodynamic monitoring using steerable guide catheter to optimize mitraclip transcatheter mitral valve repair: A multicenter, proof-of-concept study.

Tang GHL, Ong LY, Kaple R, Ramlawi B, Dutta T, Zaid S, Ahmad H, Kalimi R, Undemir C, Khan A, Yudi MB, Nadir MA, Majeed F, Ali O, Skiles J, Bhim C, Cohen M, Lansman SL, Sharma SK, Kini A.

J Interv Cardiol. 2018 Dec;31(6):907-915. doi: 10.1111/joic.12557. Epub 2018 Aug 30.

7.

Health-care providers' perspectives on traditional and complementary alternative medicine of childhood cancer in Kenya.

Olbara G, Parigger J, Njuguna F, Skiles J, Sitaresmi MN, Gordijn S, van de Ven P, Kaspers G, Mostert S.

Pediatr Blood Cancer. 2018 Dec;65(12):e27309. doi: 10.1002/pbc.27309. Epub 2018 Jul 26.

PMID:
30051647
8.

Health-care providers' perspectives on health-insurance access, waiving procedures, and hospital detention practices in Kenya.

Mostert S, Njuguna F, van der Burgt RHM, Musimbi J, Langat S, Skiles J, Seijffert A, Sitaresmi MN, Vik TA, van de Ven PM, Kaspers GJL.

Pediatr Blood Cancer. 2018 Aug;65(8):e27221. doi: 10.1002/pbc.27221. Epub 2018 May 9.

PMID:
29741267
9.

Influence of health insurance status on paediatric non-Hodgkin's lymphoma treatment in Kenya.

Martijn HA, Njuguna F, Olbara G, Langat S, Skiles J, Martin S, Vik T, van de Ven PM, Kaspers GJ, Mostert S.

BMJ Paediatr Open. 2017 Aug 11;1(1):e000149. doi: 10.1136/bmjpo-2017-000149. eCollection 2017.

10.

CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.

Skiles JL, Chiang C, Li CH, Martin S, Smith EL, Olbara G, Jones DR, Vik TA, Mostert S, Abbink F, Kaspers GJ, Li L, Njuguna F, Sajdyk TJ, Renbarger JL.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26854. Epub 2017 Nov 8.

11.

Wilms Tumor Treatment Outcomes: Perspectives From a Low-Income Setting.

Njuguna F, Martijn HA, Kuremu RT, Saula P, Kirtika P, Olbara G, Langat S, Martin S, Skiles J, Vik T, Kaspers GJL, Mostert S.

J Glob Oncol. 2016 Dec 21;3(5):555-562. doi: 10.1200/JGO.2016.005389. eCollection 2017 Oct.

12.

Low serum albumin levels prior to pediatric allogeneic HCT are associated with increased need for critical care interventions and increased 6-month mortality.

Teagarden AM, Skiles JL, Beardsley AL, Hobson MJ, Moser EAS, Renbarger JL, Rowan CM.

Pediatr Transplant. 2017 Sep;21(6). doi: 10.1111/petr.13016. Epub 2017 Jul 2.

13.

Glutathione-S-transferase P1 may predispose children to a decline in pulmonary function after stem cell transplant.

Stark J, Renbarger J, Slaven J, Yu Z, Then J, Skiles J, Davis S.

Pediatr Pulmonol. 2017 Jul;52(7):916-921. doi: 10.1002/ppul.23678. Epub 2017 Feb 2.

14.

Health-Care Providers' Perspectives towards Childhood Cancer Treatment in Kenya.

Njuguna F, van der Burgt RH, Seijffert A, Musimbi J, Langat S, Skiles J, Sitaresmi MN, van de Ven PM, Kaspers GJ, Mostert S.

Asian Pac J Cancer Prev. 2016;17(9):4445-4450.

15.

Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya.

Njuguna F, Martijn H, Langat S, Musimbi J, Muliro H, Skiles J, Vik T, Sitaresmi MN, van de Ven PM, Kaspers GJ, Mostert S.

Pediatr Hematol Oncol. 2016 Apr;33(3):186-99. doi: 10.3109/08880018.2016.1169566.

16.

Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.

Buckle G, Maranda L, Skiles J, Ong'echa JM, Foley J, Epstein M, Vik TA, Schroeder A, Lemberger J, Rosmarin A, Remick SC, Bailey JA, Vulule J, Otieno JA, Moormann AM.

Int J Cancer. 2016 Sep 15;139(6):1231-40. doi: 10.1002/ijc.30170. Epub 2016 May 18.

17.

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N, Haneline LS, Robertson KA, Skiles J, Diaz-Ricart M, Carreras E, Renbarger J, Hanash S, Bies RR, Paczesny S.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1739-45. doi: 10.1016/j.bbmt.2015.07.004. Epub 2015 Jul 11.

18.

Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.

Lavoie Smith EM, Li L, Chiang C, Thomas K, Hutchinson RJ, Wells EM, Ho RH, Skiles J, Chakraborty A, Bridges CM, Renbarger J.

J Peripher Nerv Syst. 2015 Mar;20(1):37-46. doi: 10.1111/jns.12114.

19.

Parental experiences of childhood cancer treatment in Kenya.

Njuguna F, Mostert S, Seijffert A, Musimbi J, Langat S, van der Burgt RH, Skiles J, Sitaresmi MN, van de Ven PM, Kaspers GJ.

Support Care Cancer. 2015 May;23(5):1251-9. doi: 10.1007/s00520-014-2475-x. Epub 2014 Oct 17.

PMID:
25318695
20.

Two overlooked contributors to abandonment of childhood cancer treatment in Kenya: parents' social network and experiences with hospital retention policies.

Mostert S, Njuguna F, Langat SC, Slot AJ, Skiles J, Sitaresmi MN, van de Ven PM, Musimbi J, Vreeman RC, Kaspers GJ.

Psychooncology. 2014 Jun;23(6):700-7. doi: 10.1002/pon.3571. Epub 2014 May 1.

PMID:
24789661
21.

Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.

Jayachandran D, Ramkrishna U, Skiles J, Renbarger J, Ramkrishna D.

CPT Pharmacometrics Syst Pharmacol. 2014 Apr 16;3:e110. doi: 10.1038/psp.2014.6.

22.

Abandonment of childhood cancer treatment in Western Kenya.

Njuguna F, Mostert S, Slot A, Langat S, Skiles J, Sitaresmi MN, van de Ven PM, Musimbi J, Muliro H, Vreeman RC, Kaspers GJ.

Arch Dis Child. 2014 Jul;99(7):609-14. Epub 2014 Mar 28.

PMID:
24681695
23.

Influence of health-insurance access and hospital retention policies on childhood cancer treatment in Kenya.

Mostert S, Njuguna F, van de Ven PM, Olbara G, Kemps LJ, Musimbi J, Strother RM, Aluoch LM, Skiles J, Buziba NG, Sitaresmi MN, Vreeman RC, Kaspers GJ.

Pediatr Blood Cancer. 2014 May;61(5):913-8. doi: 10.1002/pbc.24896. Epub 2013 Dec 17.

PMID:
24347434
24.

Mentoring future Kenyan oncology researchers.

Moormann A, Skiles J, Koros E, Asirwa FC, Busakhala N, Loehrer P.

Infect Agent Cancer. 2013 Oct 7;8(1):40. doi: 10.1186/1750-9378-8-40.

25.

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab.

Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB.

Pediatr Blood Cancer. 2013 Jan;60(1):101-9. doi: 10.1002/pbc.24188. Epub 2012 Apr 22.

26.

Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.

Skiles JL, Imel EA, Christenson JC, Bell JE, Hulbert ML.

J Clin Oncol. 2011 Nov 10;29(32):e779-82. doi: 10.1200/JCO.2011.35.9604. Epub 2011 Oct 3. No abstract available.

PMID:
21969513
27.

Landing on the Hudson River: lessons for health care.

Silbaugh B, Skiles J.

Physician Exec. 2010 May-Jun;36(3):22-6, 28-9.

PMID:
20499517
28.

End-of-life experiences in adolescents dying with cancer.

Bell CJ, Skiles J, Pradhan K, Champion VL.

Support Care Cancer. 2010 Jul;18(7):827-35. doi: 10.1007/s00520-009-0716-1. Epub 2009 Aug 29.

PMID:
19727847
29.

Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.

Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW.

J Med Chem. 2009 Jun 11;52(11):3523-38. doi: 10.1021/jm801394m.

PMID:
19422229
30.

Update of computed tomography and its increasing clinical applications.

Skiles JW, Delgado P.

Mo Med. 2005 Mar-Apr;102(2):116-9.

PMID:
15822359
31.

The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.

Skiles JW, Gonnella NC, Jeng AY.

Curr Med Chem. 2004 Nov;11(22):2911-77. Review.

PMID:
15544483
32.

A case of megacolon in Rio Grande valley as a possible case of Chagas disease.

Reinhard K, Fink TM, Skiles J.

Mem Inst Oswaldo Cruz. 2003;98 Suppl 1:165-72.

33.

Clinical, echocardiographic, and biomechanical differences in mitral valve prolapse affecting one or both leaflets.

Mills WR, Barber JE, Skiles JA, Ratliff NB, Cosgrove DM, Vesely I, Griffin BP.

Am J Cardiol. 2002 Jun 15;89(12):1394-9.

PMID:
12062734
34.

Transesophageal echocardiographic (TEE) evaluation of ventricular function.

Skiles JA, Griffin BP.

Cardiol Clin. 2000 Nov;18(4):681-97, vii. Review.

PMID:
11236160
35.

The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.

Skiles JW, Gonnella NC, Jeng AY.

Curr Med Chem. 2001 Mar;8(4):425-74. Review.

PMID:
11172697
36.

Wide QRS complex tachycardia: ECG differential diagnosis.

Brady WJ, Skiles J.

Am J Emerg Med. 1999 Jul;17(4):376-81.

PMID:
10452438
37.

Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase.

Singh HN, Blancuzzi V, Greenwood S, Skiles JW, O'Byrne EM.

Inflamm Res. 1997 Aug;46 Suppl 2:S153-4. No abstract available.

PMID:
9297557
38.

Inhibition of human leukocyte elastase by N-substituted peptides containing alpha,alpha-difluorostatone residues at P1.

Skiles JW, Miao C, Sorcek R, Jacober S, Mui PW, Chow G, Weldon SM, Possanza G, Skoog M, Keirns J, et al.

J Med Chem. 1992 Dec 25;35(26):4795-808.

PMID:
1479581
39.

Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones.

Skiles JW, Fuchs V, Miao C, Sorcek R, Grozinger KG, Mauldin SC, Vitous J, Mui PW, Jacober S, Chow G, et al.

J Med Chem. 1992 Feb 21;35(4):641-62.

PMID:
1542092
40.

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.

Wu JC, Warren TC, Adams J, Proudfoot J, Skiles J, Raghavan P, Perry C, Potocki I, Farina PR, Grob PM.

Biochemistry. 1991 Feb 26;30(8):2022-6.

PMID:
1705436
41.

Inhibition of human leukocyte elastase by N-substituted tripeptide trifluoromethyl ketones.

Skiles JW, Fuchs V, Chow G, Skoog M.

Res Commun Chem Pathol Pharmacol. 1990 Jun;68(3):365-74.

PMID:
2385759
42.

Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity.

Barton JN, Piwinski JJ, Skiles JW, Regan JR, Menard PR, Desai R, Golec FS, Reilly LW, Goetzen T, Ueng SN, et al.

J Med Chem. 1990 Jun;33(6):1600-6.

PMID:
2342054
43.

Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro.

Merluzzi VJ, Cipriano D, McNeil D, Fuchs V, Supeau C, Rosenthal AS, Skiles JW.

Res Commun Chem Pathol Pharmacol. 1989 Dec;66(3):425-40.

PMID:
2558406
44.

Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity.

Skiles JW, Suh JT, Williams BE, Menard PR, Barton JN, Loev B, Jones H, Neiss ES, Schwab A, Mann WS, et al.

J Med Chem. 1986 May;29(5):784-96.

PMID:
3009814
45.

Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.

Suh JT, Skiles JW, Williams BE, Youssefyeh RD, Jones H, Loev B, Neiss ES, Schwab A, Mann WS, Khandwala A, et al.

J Med Chem. 1985 Jan;28(1):57-66.

PMID:
2981324
46.

Inhibition of angiotensin-converting enzyme by dipeptide analogs.

Schwab A, Macerata R, Rogers W, Barton J, Skiles J, Khandwala A.

Res Commun Chem Pathol Pharmacol. 1984 Sep;45(3):339-45.

PMID:
6095384
47.

Chronic right lower quadrant pain with urinary symptoms.

ETHERTON EL, SKILES JH, SILER CA.

Ill Med J. 1949 Jun;95(6):369. No abstract available.

PMID:
18151307
48.

Removal of metallic bodies with the aid of a metal locator.

SKILES JH.

Bull Oak Park Ill. 1947 Jan;1(1):15-7. No abstract available.

PMID:
20257622

Supplemental Content

Loading ...
Support Center